Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Yeon Hee Park
With
The observation period of this study is until the discontinuation after administration of T-Dxd or until 8 Cycle. * Acute phase: 0 -24 hours after T-DXd administration * Delayed phase: \>24-120 hours after T-DXd administration * Overall phase: 0-120 hours after T-DXd administration * Long-delayed phase: \>120-504 hours * Extended overall phase: 0-504 hours Primary objectives: to evaluate the efficacy and safety of NEPA for CINV prevention in advanced breast cancer patients receiving at least 2 cycles of T-DXd across all defined assessment periods (acute, delayed, overall, long-delayed, and extended overall phases).
Age
19–any
Sex
ALL
Healthy volunteers
Not accepted